GlassScriptPhysician profile
Yafa Minazad
NPI 1982636122
$23,782.20
in general payments reported to CMS, 2019-2025
59 companies · $1,296 in 2025
The $1,296 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $3,783 · 2021: $2,865 · 2022: $1,599 · 2023: $1,349 · 2024: $1,333 · 2025: $1,296.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,979.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,978.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $12,663.53 | 2019-2025 | Austedo Xr, Austedo Xr, Austedo |
| Ucb, INC. | $3,109.13 | 2019-2025 | Briviact, Fintepla, Nayzilam |
| Abbvie INC. | $1,250.23 | 2021-2025 | |
| Covidien LP | $556.19 | 2019-2020 | |
| Sk Life Science, INC. | $524.91 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $406.55 | 2019-2025 | |
| Celgene Corporation | $337.54 | 2021-2025 | Zeposia |
| Tela Bio, INC. | $299.94 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $296.48 | 2019-2022 | |
| Pfizer INC. | $292.24 | 2023-2025 | |
| Eisai INC. | $273.84 | 2019-2025 | |
| Medtronic, INC. | $273.00 | 2022-2023 | Signia |
| Allergan, INC. | $268.34 | 2019-2022 | |
| Alexion Pharmaceuticals, INC. | $250.22 | 2021-2023 | Soliris |
| Jazz Pharmaceuticals INC. | $215.32 | 2022-2025 | Epidiolex |
Show all 59 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yafa Minazad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.